My primary research interest as a pediatric oncologist/stem cell transplant physician is in personalized medicine and pharmacogenomics in the treatment of childhood cancers. Our work involves a major effort to identify biomarkers of drug toxicity and efficacy in the treatment of pediatric cancers. The ultimate goal is to use these biomarkers to develop simple, robust and practical clinical predictors of response to medications in individual patients that can be used to optimize dosing in the treatment of children, many of whom have curable malignancies.
Dr. Renbarger's research interests include:
- The development and use of personalized medicine and pharmacogenomics in the treatment of childhood cancers. Her work involves a major effort to identify biomarkers of drug toxicity and efficacy in the treatment of pediatric cancers.
Subject area:
- Pediatric Musculoskeletal Disease
